Alan Schneider, MD
Clinical Cardiac Electrophysiology · Silver Spring, MDNPI 1073692885
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,121 of the $1,463 with a category attached, or 76.6%. Abbott accounts for 97.4% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $1,247 and has fallen 97.0% since, to $38 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in MD, where the typical reported total is $15,262.
Across 19 payments — averaging $76.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Philips North America LLC$38
What the payments were for
- Travel & lodging$1,12177%
- Food & beverage$34223%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 18 | $1,425 |
| Philips North America LLC | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$1,021
How this compares
$1,463 in reported general payments places this provider in the 10th percentile of 63 clinical cardiac electrophysiology providers in Maryland.
See all clinical cardiac electrophysiology providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 493 | $681,627 |
| XareltoRivaroxaban | 107 | $163,141 |
| EntrestoSacubitril/Valsartan | 72 | $113,828 |
| Repatha SureclickEvolocumab | 14 | $22,024 |
| Metoprolol Succinate | 356 | $8,314 |
| SavaysaEdoxaban Tosylate | 11 | $5,294 |
| Atorvastatin Calcium | 300 | $4,684 |
| Amiodarone Hcl | 112 | $4,322 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 14 | $2,784 |
| Amlodipine Besylate | 305 | $2,762 |
| Propafenone Hcl ErPropafenone Hcl | 12 | $2,278 |
| Droxidopa | 16 | $2,248 |
| Rosuvastatin Calcium | 89 | $2,116 |
| Valsartan | 27 | $1,665 |
| Flecainide Acetate | 39 | $1,627 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Silver Spring
- Pirooz MofradSilver Spring$26K
- Luc OkeSilver Spring$22K
- Sean BeinartRockville$315K
- Charles LoveBaltimore$238K
- Hugh CalkinsBaltimore$202K
- Paresh ShahBaltimore$97K
- Helen BaroldRockville$83K
- Jonathan ChrispinBaltimore$77K
- Sung LeeTakoma Park$68K
- Stephen ShorofskyBaltimore$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.